FDA

US food recalls expand to include 60,000lbs of chicken nuggets

US food recalls expand to include 60,000lbs of chicken nuggets

This year has included several big food recalls in the US, something that doesn't appear to be slowing down. In addition to the ongoing massive beef recalls, the USDA and FDA have both reported new and expanded food recalls over the past few days. Consumers in various parts of the US are warned to avoid certain pasta, salad, and chicken products over the risk of parasites and other contamination.

Continue Reading

COVID-19 vaccine rules see FDA try to win over anti-vaxxers

COVID-19 vaccine rules see FDA try to win over anti-vaxxers

Fearing skepticism or even outright refusal among some Americans to consider a COVID-19 vaccination, the US Food and Drug Administration has preemptively published its guidelines for the development of a lasting coronavirus treatment. The recommendations, released today, cover the process by which the FDA will eventually approve potential COVID-19 vaccines, at least in part to try to bring "anti-vaxx" advocates onboard.

Continue Reading

FDA warns public to trash this hand sanitizer for fear of methanol

FDA warns public to trash this hand sanitizer for fear of methanol

Wood alcohol may have found its way into a certain set of hand sanitizer bottles released to the public earlier this year. One voluntary recall was announced on behalf of Saniderm Advanced Hand Sanitizer, for their 1-liter bottles of consumer-level product. The recall was done after a news alert from the Food and Drug Administration for related toxic hand sanitizer manufacturing done by Eskbiochem SA de CV in Mexico.

Continue Reading

Popular children’s medicines recalled, but not for the reason you think

Popular children’s medicines recalled, but not for the reason you think

The FDA published an advisory late last week revealing that multiple children's medications have been recalled, including Robitussin and Dimetapp. The recall covers two lots of the over-the-counter medication, which are sold as products for coughing and colds in 4oz and 8oz sizes. According to the FDA, the recall was voluntarily initiated by GSK Consumer Healthcare after the issue was discovered.

Continue Reading

EndeavorRx is FDA’s first game-based therapy approval

EndeavorRx is FDA’s first game-based therapy approval

Computer games get a bad rap for their addictive elements and violent content but those conveniently ignore the wide variety of genres, content, and purposes available in such a broad medium. Even discounting explicitly educational games, there is still a long list of games that go beyond entertainment. The latest and perhaps strongest proof of games' potential for good is the FDA's approval of the EndeavorRx mobile game for kids diagnosed with ADHD, the first time the agency has given its thumbs-up to a game.

Continue Reading

FDA pulls authorization for COVID-19 treatment Trump touted

FDA pulls authorization for COVID-19 treatment Trump touted

Hydroxychloroquine can no longer be used for COVID-19 treatment in the US, with the FDA revoking its emergency use authorization for the controversial drug touted by President Trump. Chloroquine phosphate and hydroxychloroquine sulfate had been credited with reducing coronavirus infection after an early study, but critics were quick to dispute both those findings and the drugs' efficacy.

Continue Reading

Another batch of metformin recalled over cancer-causing impurity

Another batch of metformin recalled over cancer-causing impurity

The FDA has revealed that another lot of metformin, a drug commonly used by type-2 diabetics, have been recalled over the presence of an impurity that is linked to the development of cancer. The recall announcement follows similar recent recalls from multiple companies after the FDA published the results of testing on metformin samples.

Continue Reading

Popular antidepressant in short supply because of pandemic, says FDA

Popular antidepressant in short supply because of pandemic, says FDA

The coronavirus pandemic has caused a spike in demand for depression and anxiety medication. One popular SSRI anti-depressant that is often prescribed to treat both depression and anxiety is in short supply, the FDA warned in a document published on May 29. The shortage applies mostly to higher doses of the drug with the FDA estimating it will take 60 days to clear the shortages.

Continue Reading

FDA warns popular diabetes drug has cancer risk, seeks multiple recalls

FDA warns popular diabetes drug has cancer risk, seeks multiple recalls

In a statement this week, the Food and Drug Administration warned that its laboratory has discovered impurities in some batches of popular diabetes drug metformin that may be a cancer risk. The discovery involves "several lots" of the extended-release (ER) version of metformin, prompting the agency to seek voluntary drug recalls from five different companies.

Continue Reading

Popular thyroid drug recalled because it’s ‘super potent’ says FDA

Popular thyroid drug recalled because it’s ‘super potent’ says FDA

The FDA has alerted consumers about a recent recall from Acella Pharmaceuticals, which has recalled its popular natural thyroid product after discovering that it is too potent, putting patients at risk of getting too much thyroid hormone. Though hypothyroidism can cause a number of health problems, too much thyroid hormone can be deadly, causing high blood pressure, an irregular heartbeat, and more.

Continue Reading

FDA says some CBD oil recalled across US over risk of lead poisoning

FDA says some CBD oil recalled across US over risk of lead poisoning

A batch of CBD oil that was distributed nationwide in the US has been recalled after it tested positive for high levels of lead. The FDA warns that consuming this CBD oil could potentially result in lead poisoning, a serious condition that could, among other things, result in kidney damage and shock. There haven't been any consumer complaints related to the CBD, however.

Continue Reading

FDA warns this rapid COVID-19 test is giving false-negatives

FDA warns this rapid COVID-19 test is giving false-negatives

One of the coronavirus tests currently in use in the US to track COVID-19 cases may be giving more false-negative results than expected, the FDA has warned, raising the possibility that infected people may be unwittingly told that they do not have the disease. The US Food and Drug Administration warned that Abbott's ID NOW test could be inaccurate, and giving those with COVID-19 a false sense of security.

Continue Reading

1 2 3 4 Next